The Level of Free Fetal DNA as Precise Noninvasive Marker for Chromosomal Aneuploidies: First Results from BALTIC Region

Background and objectives: Noninvasive prenatal testing (NIPT), which has been introduced clinically since 2011, uses the circulating cell-free fetal DNA in the maternal blood to evaluate the risk of a chromosomal anomaly. The aim of this study was to examine the effectiveness of NIPT using a single...

Descripción completa

Detalles Bibliográficos
Autores principales: Serapinas, Danielius, Boreikaitė, Evelina, Bartkevičiūtė, Agnė, Norvilaitė, Kristina, Narbekovas, Andrius, Bartkevičienė, Daiva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694133/
https://www.ncbi.nlm.nih.gov/pubmed/33143018
http://dx.doi.org/10.3390/medicina56110579

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694133/
https://www.ncbi.nlm.nih.gov/pubmed/33143018
http://dx.doi.org/10.3390/medicina56110579

Ejemplares similares